As a premier biologics contract manufacturer, Gallus owns and operates a 200,000ft2
facility which has been inspected and
approved by every major regulatory body including the FDA, EMA, HealthCanada, ANVISA and PMDA. Gallus' team of 200+ dedicated professionals offers process development and mammalian cell culture cGMP manufacturing for clinical and commercial purposes. Today, Gallus produces leading commercial biologics products, Remicade®
and Stelara® , which are
distributed globally. Gallus is rapidly being recognized as the better alternative by biotech and pharmaceutical companies ZKR ZDQW D ÁH[LEOH GHSHQGDEOH F*03 PDQXIDFWXULQJ SDUWQHU IRU WKHLU SURGXFWV
Introducing SuiteSPACE™ production capacity, designed with the client to meet their product needs. SuiteSPACE™
- a unique virtual ownership business model - purpose built clinical or commercial mammalian allows customers the security and
VFKHGXOLQJ ÁH[LELOLW\ WKH\ GHVLUH ZLWK WKH FRQÀGHQFH DQG DVVXUDQFH WKH\ H[SHFW IURP D OLFHQVHG PDQXIDFWXULQJ IDFLOLW\
Come visit Gallus's Clinical Services Suite (CSS) for supply of Phase I, II and III (pre-process validation) material. The CSS is GHVLJQHG IRU EDWFK IHG EDWFK DQG SHUIXVLRQ WHFKQRORJ\ LQFRUSRUDWLQJ D QHZ state-of-the-art, single-use technology.
Need a true manufacturing partner? Rely on Gallus. Call (+1) 314 733-3448 or visit www.gallusbiopharma.com
/ VFDOH ;FHOOHUH[® )OH[)DFWRU\® ZLWK